Cardio Diagnostics Holdings is trading at $2.06, up 12.82%, with buying appearing linked to positioning ahead of estimated August 13 earnings.

  • Shares rose 7.02% on August 11 and 7.83% on August 7.
  • The company scheduled an August 20 investor call covering testing programs, reimbursement progress, and growth initiatives.
  • Broader markets are supportive, with the Nasdaq up 0.78%.